Viking Therapeutics closes $292.5 million convertible senior notes offering
Underwriters exercised their option for an additional $33.75 million of notes. Net proceeds from the concurrent stock and note offerings were about $547.8 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.